Back to all biomarkers
Metabolic

Fasting Insulin

Insulin levels after fasting — one of the earliest indicators of insulin resistance, years before glucose rises.

Optimal Range

2-6 μIU/mL (optimal) · < 10 μIU/mL (normal)

Risk-Stratified Targets

Population / ContextTarget
Optimal2–6 μIU/mL
Acceptable< 8 μIU/mL
Suggestive of insulin resistance8–12 μIU/mL
Insulin resistant> 12 μIU/mL
HOMA-IR — excellent insulin sensitivity< 1.0
HOMA-IR — normal1.0–2.5
HOMA-IR — insulin resistant> 2.5

Why It Matters

Fasting insulin rises years before glucose in the progression toward type 2 diabetes. It is one of the most actionable early metabolic warning signs and responds readily to lifestyle interventions.

Understanding Fasting Insulin

Fasting insulin may be the single most underutilized biomarker in routine medicine. Despite being inexpensive and widely available, it is rarely ordered in standard checkups — yet it provides crucial information about metabolic health that fasting glucose alone cannot reveal. Fasting insulin measures how hard your pancreas is working to maintain normal blood sugar, and it rises years to decades before glucose levels become abnormal.

The pathophysiology is straightforward: as tissues become resistant to insulin's effects (due to excess visceral fat, physical inactivity, chronic inflammation, or genetic predisposition), the pancreas compensates by secreting more insulin. During this compensatory phase, fasting glucose remains normal because the extra insulin is sufficient to force glucose into cells. This can persist for 10–15 years before the pancreas eventually fails to keep up and glucose rises into the prediabetic range.

A fasting insulin level above 8–10 μIU/mL in the context of normal fasting glucose is a strong signal of insulin resistance. The HOMA-IR calculation (fasting glucose × fasting insulin ÷ 405) provides a more precise estimate — values below 1.0 are ideal, while values above 2.5 suggest clinically significant insulin resistance. Importantly, insulin resistance is highly responsive to lifestyle interventions: regular exercise (particularly resistance training and HIIT), dietary carbohydrate moderation, sleep optimization, and weight loss can dramatically improve insulin sensitivity.

Key Research

Role of Insulin Resistance in Human Disease

Reaven GM · Diabetes (1988)

Key finding: Landmark paper establishing insulin resistance as a central driver of cardiovascular disease, hypertension, and metabolic syndrome — which Reaven originally termed 'Syndrome X.'

Detection of Diabetes Mellitus In Situ (Occult Diabetes)

Kraft JR · Lab Med (1975)

Key finding: Demonstrated that hyperinsulinemia (elevated insulin with normal glucose) precedes the development of type 2 diabetes by many years, and that insulin testing detects metabolic dysfunction far earlier than glucose.